Volatile Anesthetic Agent Reflectors and Their Importance

Background

1. Rapid consumption - ICU ventilators operate at high fresh gas flow rates, which carry the anesthetic away quickly, making continuous delivery expensive and wasteful.
2. Environmental contamination - Without closed-circuit recapture, exhaled anesthetic vapors pollute the ICU air, posing occupational health hazards to staff.

• Miller's Anesthesia, 10e, p. 2317

What Are Volatile Anesthetic Reflectors?

How Does the AnaConDa Work?

1. Vaporization

• Liquid volatile anesthetic (isoflurane or sevoflurane) is infused via a standard syringe pump into the device.
• The liquid passes through a porous evaporator rod, which vaporizes it into the breathing gas stream before the patient inhales.

2. Inhalation Phase

• The patient breathes in anesthetic vapor normally through the device.
• The device adds negligible dead space (~100 mL increase to breathing circuit).

3. Exhalation and "Reflection"

• Exhaled gases pass through an activated carbon felt reflector.
• This carbon layer rapidly adsorbs (traps) ~90% of exhaled volatile anesthetic molecules with high efficiency.
• CO₂ and other exhaled gases pass through freely (they are not adsorbed).

4. Next Inspiratory Cycle

• During inspiration, fresh carrier gas flowing through the device desorbs the adsorbed anesthetic from the carbon layer.
• This anesthetic is "reflected" back toward the patient for re-breathing in the next cycle.

5. Monitoring

• A gas sampling port connects to a bedside gas analyzer, providing real-time breath-by-breath monitoring of:
  • Inspired volatile agent concentration (FiVA)
  • End-tidal volatile agent concentration (EtVA, corresponding to MAC level)
  • End-tidal CO₂
• Miller's Anesthesia, 10e, p. 2317

Efficiency and Agent Consumption

• Reflector efficiency: ~90% - only ~10% of exhaled anesthetic is lost to waste gases.
• Agent consumption is theoretically equivalent to an anesthesia machine operating at fresh gas flows of 0.5-1 L/min - a significant reduction versus open ICU ventilator delivery.
• The reflector capacity of AnaConDa is 10 mL of anesthetic vapor per expired breath (e.g., 1 vol% in 1000 mL tidal volume, or 2 vol% in 500 mL tidal volume).
• Infusion rates must be increased proportionally with minute ventilation to maintain target end-tidal concentrations.

The Mirus Device - Additional Features

• Ability to deliver desflurane (low blood:gas solubility coefficient - fastest recovery)
• Automated closed-loop control of end-tidal volatile concentration, removing manual titration
• Minimum recommended tidal volume: 300 mL (vs. 350 mL for AnaConDa)

Clinical Indications for Volatile Anesthetic Reflectors in the ICU

1. ICU Sedation (Primary Use)

• Faster awakening and extubation - A 2025 systematic review and meta-analysis of 15 RCTs (n=1185 patients) found that inhaled sedation via ACD shortened awakening time, extubation time, and ICU length of stay (non-cardiac ICU) compared to IV sedation [PMID: 39972505].
• Lung elimination - Volatile agents are excreted predominantly via the lungs, independent of hepatic or renal metabolism. This is advantageous in patients with multi-organ dysfunction where IV sedative clearance is impaired.
• Predictable, titratable sedation - End-tidal gas monitoring provides a real-time cerebral concentration surrogate (MAC equivalent), allowing precise depth-of-sedation titration and preventing inadvertent oversedation.
• Reduced accumulation - Unlike propofol or benzodiazepines, volatile agents do not accumulate in peripheral compartments with prolonged use.
• Reduced PTSD - Volatile agents may cause anterograde amnesia with less risk of PTSD compared to inadequate sedation with IV agents.

2. Refractory Bronchospasm

• Volatile anesthetics (especially isoflurane and sevoflurane) are potent bronchodilators via direct smooth muscle relaxation.
• Used as rescue therapy in status asthmaticus unresponsive to conventional bronchodilators.

3. Status Epilepticus

• Volatile agents possess antiepileptic properties and can be delivered via reflector in refractory or super-refractory status epilepticus when IV agents are failing.

4. Cardioprotection and Cerebroprotection

• Volatile anesthetics exhibit anesthetic preconditioning and postconditioning effects that may protect the myocardium during or after ischemia-reperfusion (e.g., post-cardiac surgery patients transitioning from OR to ICU).
• Potential neuroprotective effects are also being studied.

Environmental and Safety Considerations

• Expired volatile agent not captured by the reflector is scavenged at the ventilator expiratory port.
• A passive charcoal adsorber or active scavenging system should be connected to minimize room air contamination.
• ICU room air recycling rates vary, so volatile atmospheric levels should be monitored using infrared spectrophotometric monitors or dosimeters.
• Filling the AnaConDa syringe must be performed by trained personnel to minimize spillage and inhalation exposure.
• The AnaConDa unit is replaced every 24 hours.

Limitations

Summary of Importance

1. Break the OR barrier - Enable safe delivery of inhaled volatile agents in the ICU using any standard ventilator.
2. Reduce agent consumption by ~90% - Making volatile ICU sedation economically and environmentally feasible.
3. Improve sedation outcomes - Faster awakening, faster extubation, shorter ICU stay versus IV sedation (Level 1 evidence, 2025 meta-analysis).
4. Expand therapeutic reach - Provide access to volatile agent bronchodilation, anticonvulsant properties, and organ-protective effects in critically ill patients.
5. Enable real-time pharmacodynamic monitoring - End-tidal gas concentration monitoring allows unprecedented precision in sedation titration.

Recent Evidence Update (2025): A systematic review and meta-analysis [PMID: 39972505] including 15 RCTs confirmed that inhaled sedation via ACD significantly shortens awakening and extubation times compared to IV sedation, with no difference in PONV rates. This supports volatile reflectors as a safe and effective alternative sedation strategy in critically ill patients.